步长制药(603858.SH)：石榴云医在美国纳斯达克证券交易所挂牌上市

Core Viewpoint - The company BuChang Pharmaceutical (603858.SH) announced that its associate company, Guangzhou Qilekang Digital Health Medical Technology Co., Ltd. (referred to as "Qilekang Digital Medical"), will be listed on the NASDAQ under the VIE model on October 8, 2025, with the stock code POM [1] Group 1 - The substantial controlling company of Qilekang Digital Medical, POMDOCTOR LIMITED, is also known as "Shiliu Yunyi" [1] - After the global offering, BuChang Pharmaceutical, through its wholly-owned subsidiary DanHong (H.K.) Technology Limited, will hold 2,957,613 shares of Shiliu Yunyi, representing approximately 15% of the total share capital post-issuance [1]